Russel E. Kaufman, M.D., to Moderate and Speak at 2nd Annual Kentmere Genetic Testing and Utilization Management Conference in Philadelphia

WILMINGTON, Del., May 31, 2016 /PRNewswire/ -- Russel E. Kaufman, M.D., of Chestnut Hill, Pa. has been announced as moderator and speaker at Kentmere Healthcare Consulting Corporation's 2^nd Annual Genetic Testing and Utilization Management Conference, June 23-24, 2016 in Philadelphia.

Logo - http://photos.prnewswire.com/prnh/20160527/373167LOGO

Dr. Kaufman is Chief Medical Officer at Kentmere Healthcare Consulting Corporation and has been an academic leader and practicing physician in biomedicine for 35 years. He was previously President and CEO of The Wistar Institute in Philadelphia for 13 years. Prior to Wistar, he was Chief of Hematology/Oncology, Vice Dean and Vice Chancellor at Duke University, where he also established and was Director of the Molecular Pathology Laboratory. In addition to his administrative leadership positions, Dr. Kaufman has had a productive research program investigating the genetics of blood diseases and cancer.

At the conference, Dr. Kaufman will speak on the topic, "Genetic Testing: Determining Value Amidst a Sea of Marketing to Physicians, Patients and Plans. What is the Cost of the $999 Human Genome Sequence?" Is there Value for whole genome sequence at any price?

Some additional conference topics include:

• The Power of NGS: Non-Invasive Prenatal Testing and Liquid Biopsies
• Pharmacogenomics and the Basis of Targeted, Personalized Therapies: The Right Drug at the Right Time to the Right Person
• Navigating the Minefield of Genetic Testing UM; Operational, Financial and Medical

The Kentmere Genetic Testing and Utilization Management Conference is designed for Health Plans and will present the latest ideas on where they should focus their efforts for genetic testing in the future, as well as the latest news on CMS genetic testing reimbursement and American Association for Cancer Research cancer genetic testing. It is exclusively for Health Plan and ACO Medical Directors, Network Management Executives, Medical Policy and Reimbursement/Contracting personnel, as well as anyone involved in utilization management of genetic and laboratory tests.

Registration* and further information can be found at http://kentmere-healthcare-consulting.ticketleap.com/2016genetic

*Kentmere has the right to deny admission and refund ticket purchases made by or for any organization and/or person that is not a Health Plan or ACO or an employee of a Health Plan or ACO.

About Kentmere Healthcare Consulting Corporation

Since 2000, Kentmere Healthcare Consulting Corporation provides its proprietary outpatient Kentmere Laboratory Benefit Management Program™ for the managed care industry, which manages Health Plan utilization, cost, and mix of outpatient clinical, pathology, and genomic laboratory testing. Kentmere exclusively serves national and regional health plans, is not a laboratory, and does not work for or with laboratory providers.

Contact:  
Danielle Ellis, Kentmere Healthcare Consulting Corporation  
302-478-7600 / Email

SOURCE Kentmere Healthcare Consulting Corporation